We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+135.1%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$433M
AUM Growth
+$185M
Cap. Flow
-$984K
Cap. Flow %
-0.23%
Top 10 Hldgs %
96.06%
Holding
18
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
COGT icon
Cogent Biosciences
COGT
+$445K

Top Sells

Rank Stock Value
1
NERV icon
Minerva Neurosciences
NERV
+$1.43M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
1
Arvinas
ARVN
$518M
$194M 44.8%
2,283,048
– –
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$69M 15.95%
1,209,571
– –
PASG icon
3
Passage Bio
PASG
$15.8M
$63.9M 14.76%
124,896
– –
HARP
4
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$48.5M 11.21%
292,141
– –
APTX
5
DELISTED
Aptinyx Inc. Common Stock
APTX
$11.4M 2.63%
3,290,079
– –
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$6.57M 1.52%
409,611
– –
CMRX
7
DELISTED
Chimerix, Inc.
CMRX
$6.52M 1.51%
1,350,000
– –
COGT icon
8
Cogent Biosciences
COGT
$6.79B
$5.5M 1.27%
489,380
+40,494
+9% +$445K
ARAV
9
DELISTED
Aravive, Inc. Common Stock
ARAV
$5.34M 1.23%
946,423
– –
ALEC icon
10
Alector
ALEC
$165M
$5.14M 1.19%
339,569
– –
CHMA
11
DELISTED
Chiasma, Inc. Common Stock
CHMA
$4.94M 1.14%
1,135,700
– –
TECX
12
Tectonic Therapeutic
TECX
$572M
$4.4M 1.02%
26,296
– –
XFOR icon
13
X4 Pharmaceuticals
XFOR
$365M
$2.15M 0.5%
11,167
– –
CRNX icon
14
Crinetics Pharmaceuticals
CRNX
$8.86B
$1.99M 0.46%
141,000
– –
OBSV
15
DELISTED
ObsEva SA Ordinary Shares
OBSV
$1.87M 0.43%
900,501
– –
ITRM
16
DELISTED
Iterum Therapeutics
ITRM
$1.44M 0.33%
97,087
– –
PDSB icon
17
PDS Biotechnology
PDSB
$38.4M
$251K 0.06%
117,242
– –
NERV icon
18
Minerva Neurosciences
NERV
$188M
– –
-56,188
Closed -$1.43M

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q4 2020 Portfolio in Review

As of Q4 2020, New Leaf Venture Partners held 18 positions worth $433M, up 74% from $248M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

New Leaf Venture Partners's Q4 2020 filing shows 1 increased and 1 closed positions. The largest sale was Minerva Neurosciences, an estimated $1.43M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • New Leaf Venture Partners added most to Cogent Biosciences in Q4 2020, an estimated $445K increase.
  • New Leaf Venture Partners fully exited Minerva Neurosciences in Q4 2020, selling an estimated $1.43M.
  • New Leaf Venture Partners's ten largest holdings make up 96% of its $433M portfolio in Q4 2020.
  • New Leaf Venture Partners opened 0 new positions and closed 1 in Q4 2020.
  • New Leaf Venture Partners's portfolio value rose 74% quarter-over-quarter to $433M.

Based on New Leaf Venture Partners's 13F filing for Q4 2020, filed 10 Feb 2021.